Antigen tracking of the DepoVaxTM-R9F cancer vaccine using MRI

Immunovaccine Inc. is developing cancer vaccines using the company’s DepoVaxTM vaccine technology. DepoVax is a patented formulation that displays excellent tumor control and provides a long lasting and specific effect. The way by which this vaccine exerts its effect is unclear but the translational team at Immunovaccine is determined to discover its mechanism of action […]

Read More
Metabolic networks and applications to M. tuberculosis

The project involves the modeling of the metabolism of TB. I developed an algorithmic pipeline called MetaMerge, which allowed me to reconcile differences in format, nomenclature, and annotation, between two models of TB metabolism. MONGOOSE, another doctoral project of mine, is a tool for analyzing metabolic network models in exact arithmetic, resulting in consistent, reproducible […]

Read More
Utilisation des lymphocytes B humains, pour l’activation de lymphocytes T in vitro, dans une perspective thérapeutique

L’immunothérapie est un traitement prometteur pour soigner le cancer et les infections virales. Ce traitement consiste à éduquer des cellules du système immunitaire, les lymphocytes T, pour qu’ils puissent éliminer les cellules problématiques du patient. Une des grandes difficultés est de fournir de l’aide spécialisée aux lymphocytes T pour faire leur travail. Cette aide vient […]

Read More
Advanced differential mobility mass spectrometry with electron capture dissociation for the characterization of therapeutic proteins

Many new pharmaceuticals are based on large biomolecules like proteins. Even small differences in the protein structure can cause significant changes in the efficacy and safety of these drugs. Furthermore, these large molecules are difficult to characterize without advanced instrumentation and methods. Current technologies still struggle with robustness and reproducibility. This study aims to introduce […]

Read More
Advanced differential mobility mass spectrometry with electron capture dissociation for the characterization of therapeutic proteins – Year two

Many new pharmaceuticals are based on large biomolecules like proteins. Even small differences in the protein structure can cause significant changes in the efficacy and safety of these drugs. Furthermore, these large molecules are difficult to characterize without advanced instrumentation and methods. Current technologies still struggle with robustness and reproducibility. This study aims to introduce […]

Read More
ABHD6 as a novel drug target for obesity, non-alcoholic fatty liver disease (NASH) and cardiovascular disease (CVD)

Obesity, type 2 diabetes (T2D) and heart diseases have skyrocketed. Controlling glucose usage and insulin balance can substantially decrease the morbidity and improve the quality of life in affected individuals. Dysfunctional insulin action and energy balance in the body is associated with excessive non-adipose fat storage, particularly in the liver, and elevated circulating lipids, which […]

Read More